NLS Pharmaceutics AG - news published 1 - readings 18

NLS Pharmaceutics AG

ASCP Annual Meeting, Miami, May 28-May 31, 2024

T22 Neuroprotective effect of mazindol on nocturnal activity in an Orexin-B-Saporin-inducednarcoleptic-like model in Sprague-Dawley rats (Study KO-874) Eric Konofal 1,2 , Jean-Charles Bizot 3 , Christelle Peyron 4 , Fabienne Massé 3 , Anne-Laure Morel 4 , George Apostol 1 NLS Pharmaceutics AG, The Circle 6, P.O. Box, CH-8058 Zurich Airport, Switzerland - ek@nls-pharma.com APH ...